Trending Medical and health breaking news Alzheimer’s Drugs Race to FDA

Trending Medical and health breaking news Alzheimer’s Drugs Race to FDA

On June 7, 2021, the FDA approved aducanumab (Aduhelm), an Alzheimer’s disease treatment targeting amyloid beta, using the accelerated approval pathway. As part of our review of 2021’s top stories, we look ahead at what the Alzheimer’s drug landscape looks like in the wake of the landmark FDA decision. No small part of the controversy…